Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Thermo Scientific Teams with NRLs on New European Regulation

Published: Wednesday, September 03, 2014
Last Updated: Wednesday, September 03, 2014
Bookmark and Share
Allowing GC-MS/MS to confirm dioxins in feed and food.

European laboratories testing feed and food for dioxins and dioxin-like substances now have lower-cost, smaller-footprint alternatives to high-resolution mass spectrometers (HRMS) for confirming levels of the toxic contaminants, thanks to a new European Union regulation.

Thermo Fisher Scientific worked closely with national reference labs (NRLs) in the European Union to support the development of the new regulation, known as Commission Regulation (EU) No. 709/2014, which permits use of gas chromatograph-triple stage quadrupole mass spectrometers (GC-MS/MS) for confirmation.

EU regulations previously permitted the use of GC-MS/MS only to screen samples for dioxins, a group of persistent organic chemicals that can cause reproductive and developmental problems, damage the immune system, interfere with hormones and also cause cancer.

Benchtop GC-MS/MS instruments are widely used throughout the analytical community, compared to floor-standing GC-HRMS systems, which are used for more specialized applications.

“Recent advances in GC triple quadrupole MS technology allow it to be used as a tool to reliably measure these substances at the maximum permitted levels controlled by EU regulations,” said Dr. Esteban Abad- Holgado, Consejo Superior de Investigaciones Scientificas (CSIC); Barcelona, Spain. Dr. Abad-Holgado is a leading researcher of persistent organic pollutants (POPs) and a key contributor to the new EU regulation. “GC-HRMS magnetic sector technology continues to be the gold standard for analyzing the lowest levels of dioxins and dioxin-like compounds, but GC-MS/MS systems work very well for food safety testing for dioxins at EU levels.”

Dr. Abad-Holgado worked with Thermo Fisher to evaluate the recently introduced Thermo Scientific TSQ 8000 Evo GC-MS/MS system in light of the new regulation, using samples previously analyzed using GC-HRMS.

“For laboratories that still require the highest levels of performance, we offer an excellent GC-HRMS instrument,” said Paul Silcock, marketing manager, GC-MS for Thermo Fisher Scientific. “We’re now positioned to also offer a top GC-MS/MS platform for confirmatory dioxin analysis which has been recently validated against the new regulatory criteria.”

Thermo Fisher also manufactures the Thermo Scientific DFS GC-HRMS for customers requiring additional performance at ultra-trace background levels.

Thermo Fisher also worked with the UK National Reference Laboratory for Contaminants in Food and Feed at the Food and Environmental Research Agency to evaluate GC-MS/MS for confirmation of dioxins.

“Thermo Fisher has helped us to evaluate the suitability of using GC-MS/MS for official food and feed control of dioxins,” said Dr. Martin Rose of the UK NRL. “We wanted to establish whether or not this technique was at a stage where it could meet the highly demanding analytical criteria for dioxin analysis, which previously allowed only HRMS to be used as a confirmatory technique.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Acquires MTI-GlobalStem
The technology strengthens Thermo Fisher’s leadership in biosciences and provides scientists around the world with access to a wider array of advanced research products designed to help accelerate discovery using cell models.
Wednesday, November 30, 2016
Thermo Fisher Scientific Acquires MTI-GlobalStem
Thermo expands transfection and stem cell research arm by acquiring MTI-GlobalStem, specialists in cell transfection, neurobiology and stem cell research applications.
Wednesday, November 30, 2016
Thermo, Hamilton Storage Collaborate
Thermo and Hamilton Storage collaborate on new Thermo Scientific Decapper, giving users flexibility with a seamless switch between tube and rack types.
Wednesday, November 23, 2016
Thermo Fisher Submits PMA Application to FDA for Universal CDx Test
Universal CDx designed to support patient selection for specific therapies in non-small cell lung cancer and multiple drug development programs.
Tuesday, November 15, 2016
Thermo Completes $4.2B FEI Acquisition
Business will become part of Thermo Fisher’s Analytical Instruments Segment.
Thursday, September 22, 2016
Thermo Fisher Opens New Clinical Services Facility in Korea
The new site will provide local, regional and global pharmaceutical and biotech companies with a one-stop service for clinical supplies.
Thursday, September 15, 2016
Thermo Fisher, HBM Collaborate
Collaboration aims to support molecular diagnostics development in China.
Friday, July 29, 2016
Thermo, DuPont Extend Food Safety Agreement
Thermo Fisher scientific and DuPont Nutrition & Health extend BAX System Q7 Distribution agreement in Western Europe for an additional three years.
Thursday, July 14, 2016
Thermo Fisher, Cytonome/ST Announce Partnership
Partnership aims to focus on the development of a new line of flow cytometry cell sorting platforms.
Tuesday, June 28, 2016
Thermo Recognizes Tandem Mass Tag Grant Award Winners at ASMS 2016
International competition rewards three top proteomics researchers for outstanding innovation and impact.
Thursday, June 09, 2016
Native Mobile Capabilities Added to Thermo SampleManager
One of world’s most widely deployed LIMS continues to add functionality that modern labs require.
Monday, March 14, 2016
Thermo, Children’s Hospital Los Angeles Partner
Children’s Hospital Los Angeles (CHLA) and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay would be CHLA’s first NGS panel designed to target biomarkers associated with childhood cancers.
Friday, February 19, 2016
Thermo Scientific Gemini Handheld Chemical Analyzer Wins R&D 100 Award
Two-in-one portable device also earns Editor’s Choice in Analytical/Test category for 2015 by R&D Magazine.
Thursday, November 26, 2015
Thermo Scientific Signs Agreement with Novartis, Pfizer
Universal test designed for non-small cell lung cancer supports multiple drug development programs.
Thursday, November 26, 2015
Thermo Scientific Opens New GMP Clinical Services Facility in Singapore
New regional BioPharma Services hub offers larger operational space and advanced equipment to meet increasing clinical supply needs for pharma and biotech customers.
Saturday, November 21, 2015
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Diabetes Missing Link Discovered
Researchers from the University of Auckland have shown that beta catenin plays a vital role in the control of insulin release from the pancreas.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Biological Link between the Gut Microbiome and Parkinson’s Disease
The findings suggest that targeting the gut microbiome may provide a new approach for diagnosing and treating Parkinson’s disease.
How the Brain Recognizes Faces
Machine-learning system spontaneously reproduces aspects of human neurology.
Boosting Effectiveness of Asthma Therapy
A team of scientists from UCSF has developed a new treatment to dampen bronchospasm.
Improved Stability, Shelf Life of Protein Drugs
Study improves protein drug stability and extend their shelf life by tested a novel route for non-covalent protein modification.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!